{"slideshow_credits": null, "snippet": "New rules could reduce the number of men who would be prescribed the medicines, as well as coverage from insurance companies for their use.", "abstract": "Expert panel votes for Food and Drug Administration to impose strict new limitations on multibillion-dollar testosterone drug industry; recommends agency tighten labels for medicines so they are not prescribed to men who only have problems related to aging; new rules could reduce coverage from insurance companies for their use.", "section_name": "Health", "print_page": "18", "document_type": "article", "byline": {"person": [{"firstname": "Sabrina", "role": "reported", "lastname": "TAVERNISE", "rank": 1, "organization": ""}], "original": "By SABRINA TAVERNISE", "contributor": ""}, "web_url": "http://www.nytimes.com/2014/09/18/health/testosterone-drugs-fda.html", "lead_paragraph": "New rules could reduce the number of men who would be prescribed the medicines, as well as coverage from insurance companies for their use.", "headline": {"main": "F.D.A. Panel Backs Limits on Testosterone Drugs", "print_headline": "F.D.A. Panel Backs Limits on Testosterone Drugs"}, "_id": "5419d33938f0d80959e6bbcc", "word_count": "1069", "multimedia": [], "pub_date": "2014-09-18T00:00:00Z", "source": "The New York Times", "news_desk": "National", "keywords": [{"value": "Testosterone", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "Men and Boys", "name": "subject", "is_major": "N", "rank": "2"}, {"value": "Food and Drug Administration", "name": "organizations", "is_major": "Y", "rank": "3"}, {"value": "Age, Chronological", "name": "subject", "is_major": "Y", "rank": "4"}, {"value": "Hormones", "name": "subject", "is_major": "N", "rank": "5"}], "blog": [], "subsection_name": null, "type_of_material": "News"}